IP Library Granted Patent US 6,976,983
Granted Patent B2
US 6,976,983 · App. 10/459,969 · Granted Dec 20, 2005

Implantable device for delivering drugs using orifice mechanism capable of low fluid flow rates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,976,983
App. No.
10/459,969
Granted
Dec 20, 2005
Kind
B2
Abstract

An implantable device for delivering a drug includes a housing and a source of drug contained within the housing. An orifice mechanism is located at the housing and communicates with the source of drug. The orifice mechanism includes an inner member having a proximal end and a distal end and a winding helically wound around the inner member. The winding and the inner member define a first channel for carrying the drug therethrough. An inlet is at the proximal end of the winding and an outlet is at the distal end of the winding. The drug is carried by the orifice mechanism and dispensed outside of the housing.

Claims (35)

1. An implantable device for delivering a drug comprising:

a housing;

a source of drug contained within the housing;

(i) an inner member having a proximal end and a distal end;

(ii) a winding helically wound around the inner member;

(iii) the winding and the inner member defining a first channel having a helical flowpath following the curvature of the winding for carrying the drug therethrough and an inlet at the proximal end of the winding and an outlet at the distal end of the winding; and

the drug being carried along the helical flowpath and dispensed outside of the housing, wherein the drug is carried through the first channel from the inlet at the proximal end of the winding to the outlet at the distal end of the winding, and the drug dispensing from the device at the outlet at the distal end of the winding and the opening in the distal end of the body.

2. The implantable device according to claim 1 , further comprising a driving system for moving the drug to the inlet of the orifice device.

3. The implantable device according to claim 2 , wherein the driving system comprises a movable interface.

4. The implantable device according to claim 3 , wherein the driving system further comprises a swellable element abutting the movable interface.

5. The implantable device according to claim 4 , wherein the housing is a semi-permeable membrane communicating with the swellable element.

6. The implantable device according to claim 5 , wherein the driving system further comprises a densifier.

7. The implantable device according to claim 6 , wherein the densifier includes a space and the orifice mechanism is located within the space.

8. The implantable device according to claim 1 , wherein the housing includes an opening communicating with the outlet of the orifice mechanism.

9. The implantable device according to claim 1 , wherein the winding further comprises a wire.

10. The implantable device according to claim 9 , further comprising an outer member over the winding.

11. The implantable device according to claim 10 , wherein the winding and the outer member define a second channel for also carrying a drug therethrough.

12. The implantable device according to claim 11 , wherein the outer member comprises channel filling material for blocking drug flow through the second channel.

13. The implantable device according to claim 9 , wherein the wire has a circular shape in cross-section.

14. The implantable device according to claim 11 , wherein the wire has a circular shape in cross-section.

15. The implantable device according to claim 9 , wherein the wire has a hexagonal shape in cross-section.

16. The implantable device according to claim 10 , wherein the wire has a hexagonal shape in cross-section.

17. The implantable device according to claim 9 , wherein the wire has an octagonal shape in cross-section.

18. The implantable device according to claim 11 , wherein the wire has an octagonal shape in cross-section.

19. The implantable device according to claim 9 , wherein the wire has a triangular shape in cross-section.

20. The implantable device according to claim 10 , wherein the outer member is a sleeve.

21. The implantable device according to claim 10 , wherein the outer member is made of a polymer material.

22. The implantable device according to claim 21 , wherein the polymer material is PTFE.

23. The implantable device according to claim 12 , wherein the channel filling material is a glue.

24. The implantable device according to claim 9 , wherein the wire is made of a degradation-resistant material.

25. The implantable device according to claim 24 , wherein the material is a nickel titanium alloy.

26. The implantable device according to claim 24 , wherein the material is a stainless steel alloy.

27. The implantable device according to claim 24 , wherein the material is plastic.

28. The implantable device according to claim 9 , wherein the wire has a width ranging from 0.001–0.050 inches.

29. The implantable device according to claim 28 , wherein the wire has a width ranging from 0.004–0.005 inches.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2017
From: CORDIS CORPORATION
To: CARDINAL HEALTH SWITZERLAND 515 GMBH
Reel/Frame 042126/0259 →